HCV Treatment With Fluvastatin, Simvastatin to Improve Interferon Sensitivity
Status:
Terminated
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
Objective: The goal is to improve peginterferon sensitivity in previous poor responders.
"Sensitivity" here means the host's ability to kill more HCV.
Design: Twenty poor responders to prior PIFN/RBV will be given 48 weeks of statin
monotherapy. Veterans and civilians between the ages of 18 and 70 are eligible.